Greece · Delayed Price · Currency is EUR Gr. Sarantis Earnings Call Transcripts
Fiscal Year 2025
-
Profitability surged in 2025 with EBITDA up 9% and net income up 15.3%, driven by strong beauty and sun care growth and international expansion, despite flat sales. Major CapEx and digital investments set the stage for further margin and cash flow improvements in 2026.
-
H1 2025 saw marginal sales growth, but strong double-digit gains in EBITDA, EBIT, and net income, driven by Beauty, Skin Care, and Sun Care. CapEx was revised down, free cash flow and dividends increased, and international expansion—especially in the U.S.—accelerated.
Fiscal Year 2024
-
Revenue grew 24% year-over-year, with strong EBITDA and net income gains, driven by organic growth and Stella Pack integration. 2025 guidance targets further sales and margin expansion, supported by increased capex and international expansion, especially in skincare and sun care.
-
Net sales rose over 30% to €302 million, with strong organic growth and margin expansion. Beauty, personal care, and home care segments all delivered double-digit growth, while the Stella Pack acquisition and innovation initiatives further boosted results.